Joseph Leegant
Molecular pathology has emerged as a cornerstone of modern surgical oncology, offering precise diagnostic, prognostic and therapeutic insights. This review explores recent advancements in molecular pathology, focusing on novel biomarkers that have revolutionized surgical oncology. The identification and application of these biomarkers have significantly enhanced the accuracy of cancer diagnoses, informed targeted therapies and improved patient outcomes. This article delves into the molecular mechanisms, clinical applications and future prospects of these biomarkers, underscoring their critical role in the evolving landscape of surgical oncology.
Partagez cet article
English 
Spanish 
Chinese 
Russian 
German 
Japanese 
Portuguese 
Hindi 